Cryptococcosis: Update and analysis of laboratory data on the frequency of Cryptococcus gattii in

Lin X, Heitman J. The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol. 2006;60:69-105.

Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg. infect. dis. 2010;16:251-7.

Martins LMS, Wanke B, Lazéra M, Trilles L, et al. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil). Mem. Inst. Oswaldo Cruz. (online). 2011; 106:725-30.

Sorrel TC. Cryptococcus neoformans variety gattii. Med Mycol. 2001; 39:155-68.

Casadevall A, Perfect JR. Cryptococcus neoformans. Washington, DC:ASM press; 1998.

Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl. Acad. Sci. U.S.A. 2004;101: 17258-63.

Lazera MS, Gutierrez-Galhardo MC, Cavalcanti MAS, Wanke B. Criptococose. In: Dinâmica das doenças infecciosas e parasitárias. Rio de Janeiro: Guanabara Koogan. 2005; p. 1223-36.

Moretti ML, Resende MR, Lazera MS, Colombo AL, Shikanai-Yasuda MA. Consenso em cryptococcosis. Rev. Soc. Bras. Med. Trop. 2008; 41(5):524-44.

Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A. Cryptococcus: From Human Pathogen to Model Yeast. Washington, D.C.: ASM Press; 2011. 620 p.

Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellonycetidae). Taxon 2002; 51:804-6.

Kwon-Chung KJ, Varma SA. Do major species concepts suport one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006; 6:574-87.

Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J. Clin.

Microbiol. 1999; 37(3): 838-40.

Kwon-Chung KJ. Filobasidiella. In: Kurtzman CP, Fell JW, Boekhout T (Editores). The Yeasts – A Taxonomic Study. Amsterdam: Elsevier Science; 2011. v. 3, p. 1443-55.

Boekhout T, Theelen B, Diaz M, Fell JW, Hop WC, Abeln EC, et al. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology. 2001;147(4): 891-907.

Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E. IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg. Infect. Dis. 2003; 9(2): 189-95.

Hagen F, Khayhan K, Theelen B, Lolecka A, Polacheck I, Sionov E, et al. Recognition of seven species in the Cryptococcus gattii/ Cryptococcus neoformans species complex. Fungal Genet Biol. 2015; 78: 16-48

Bartlett KH, Kidd SE, Kronstad JW. The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Curr Infect Dis Rep. 2008;10: 58-65.

Trilles L, Lazera MS, Wanke B, Oliveira RV, Barbosa GG, Nishikawa MM, et al. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz. 2008; 103(5): 455-62.

Pappas PG. Cryptococcal infections in non-HIV infected patients. Trans Am Clin Climatol Assoc. 2013; 124: 61-79.

Correa MP, Oliveira EC, Duarte RR, Pardal PP, Oliveira FM, Severo LC. Cryptococcosis in children in the State of Para, Brazil. Rev. Soc. Bras. Med. Trop. 1999; 32:505-8.

Pinto Junior VT, Pone MVS, Pone SM, Campos JMS, Garrido JRP, Barros ACMW, et al. Cryptococcus gattii molecular type VGII as agent of meningitis in a healthy child in Rio de Janeiro, Brazil: report of an autochthonous case. Rev. Soc. Bras. Med. Trop. 2010; 43(6): 746-8.

Rozenbaum R, Gonçalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin. Infect. Dis. 1994;18: 369-80.

Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin. Infect. Dis. 2010; 50(3): 291-322.

Kwon-Chung KJ. Filobasidiella Kwon- Chung. In: The yeasts: a taxonomic study. San Diego: Elsevier; 2011. p.1443-55.

Kwon-Chung KJ, Polacheck I, Bennett JE. Improvement diagnostic medium for separation of Cryptococcus neoformans var. neoformans (Serotypes A and D) and Cryptococcus neoformans var. gattii (Serotypes B and C). J. Clin. Microbial. 1982; 15: 535-7.

McTaggart LR, Lei E, Susan E. Richardson SE, Hoang L, Fothergill A, Zhang SX. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 2011; 49(8): 3050-3.

Stevenson L, Drake S, Shea Y, Zelazny A, Murray P. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 2010; 48: 3482-6.

Leal AL, Faganello J, Bassanesi MC, Vainstein MH. Cryptococcus species identification by multiplex PCR. Med. Mycol. 2008; 46(4): 377-83.

Martins MA, Brighente KB, Matos TA, Vidal JE, Hipólito DDC, Pereira-Chioccola VL. Molecular diagnosis of cryptococcal meningitis in cerebrospinal fluid: comparison of primer sets for Cryptococcus neoformans and Cryptococcus gattii species complex. Braz. J. Infect. Dis. 2015;19(1): 62-7.

Mitchell TG, Freedman EZ, Meyer W, White TJ, Taylor JW. PCR Identification of Cryptococcus neoformans. In: Persing DH et al., ed Diagnostic Molecular Microbiology: principles and applications. Washington, American Society for Microbiology. 1993. p. 431-6.

Mitchell TG, White TJ, Taylor JW. Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans. J. Clin. Microbiol. 1994; 2: 253-5.

Rappelli P, Are R, Casu G, Fiori PL, Cappuccinelli P, Aceti A . Development of a Nested PCR for Detection of Cryptococcus neoformans in Cerebrospinal. J. Clin. Microbiol. 1998; 36(11): 3438-40.

Vidal JE, Boulware. Lateral Flow assay for cryptococcal antigen: an important advance to improve the continuum of HIV care and reduce cryptococcal meningitisrelated mortality. Rev. Med. Trop. São Paulo. 2015; 57(supl.19): 38-45.

Cuenca-Estrella M, Lee-Yang W, Ciblak MA, Arthington-Skaggs BA, Mellado E, Warnock DW, et al. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. agents. chemother. 2002; 46: 3644-7.

Claudino ALR, Peixoto Jr. RF, Melhem MSC, Szeszs MW, Lyon JP, Chavasco JK et al. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. Clinical isolates. Pharmazie. 2008; 63: 286-9.

Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, Bernal-Martinez L, Cuesta I, Buitrago MJ, et al. Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In VitroDetection of Antifungal Resistance in Yeast Isolates. J. Clin. Microbiol. 2010; 48(5): 1782-6.

Chen SCA, Meyer W, Sorrell TC. Cryptococcus gattii Infections. Clin. Microbiol. Rev. 2014; 27(4): 980-1023.

Bellissimo-Rodrigues F, Baciotti M, Zanatto MP, Silva JO, Martins MA, Martinez R. Cutaneous cryptococcosis due to Cryptococcus gattii in a patient on chronic corticotherapy. Rev. Soc. Bras. Med. Trop. 2010; 43:211-2.

Bonfietti LX, Pham C, Silva DC, Martins MA, Lockhart S, Melhem MSC. Diversidade de isolados clínicos de Cryptococcus gattii por Multi-locus sequence typing no Estado de São Paulo. Bol. Inst. Adolfo Lutz. 2014; 24(1):36-9.

Cardoso PH, Baroni FA, Silva EG, Nascimento DC, Martins MA, Szezs W, et al. Feline nasal granuloma due to Cryptoccocus gattii type VGII. Mycopathologia. 2013; 176(3-4): 303-7.

Castro e Silva DM, Santos DCS, Martins MA, Oliveira L, Szeszs MW, Melhem MSC. First isolation of Cryptococcus neoformans genotype VNI MAT-alpha from wood inside hollow trunks of Hymenaea courbaril. Med. Mycol. 2016; 54(1):97-102.

Espinel-Ingroff A, Aller AI, Canton E, Castanon-Olivares LR, Chowdhary A, Cordoba S, et al. Cryptococcus neoformans- Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob. Agents. Chemother. 2012; 56: 5898-906.

Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, Fothergill A, Fuller J, Hagen F, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wildtype susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob. Agents. Chemother. 2012; 56:3107-13.

Lacaz CS, Heins-Vaccari EM, Hernandez- Arriagada GL, Martins EL, Prearo CA, Corim SM, et al. Primary cutaneous cryptococcosis due to Cryptococcus neoformans var. gattii serotype B, in an immunocompetent patient. Rev. Inst. Med. Trop. Sao Paulo. 2002; 44:225-8.

Lomes NR, Melhem MSC, Szeszs MW, Martins MA, Buccheri R. Cryptococcosis in non-HIV/non-transplant patients: a brazilian case series. Med. Mycol. 2016; 54(7): 669-76.

Martins MA, Pappalardo MCSM, Melhem MSC, Pereira-Chioccola VL. Molecular diversity of serial Cryptococcus neoformans isolates from AIDS patients in the city of São Paulo, Brazil. Mem. Inst. Oswaldo Cruz. 2007; 102(7):777-84.

Martins MA, Pukinskas SRBS. Cryptococcus gattii – problemas no diagnóstico de C. neoformans e C. gattii. Bol. Inst. Adolfo Lutz . 2011; 21: 55-6.

Matsumoto MT, Baeza LC, Almeida AMF, Mendes-Giannini MJ, Melhem MSC, Pukinskas SRBS, et al. Molecular Typing And Antifungal Susceptibility Of Clinical Sequential Isolates of Cryptococcus neoformans from São Paulo, Brazil. FEMS Yeast Res. 2007; (7):152-64.

Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E, Ibero-American Cryptococcal Study Group. Molecular typing of Ibero- American Cryptococcus neoformans isolates. 2003.Emerg. Infect. Dis. 9(2):189-95.

Oliveira L, Martins MA, Vidal JE, Szeszs MW, Pappalardo MCSM, Melhem MSC. Report of filamentous formsin a mating typeVNI clinical sequential isolates of Cryptococcus neoformans from an HIV virus-infected patients. Med Mycol Case Rep. 2014; 7: 4-7.

Pappalardo MCSM, Melhem MSC. Cryptococcosis: A review of the brazilian experience for the disease. Rev. Inst. Med. Trop. São Paulo. 2003; 45(6): 299-305.

Silva DC, Martins MA, Szeszs MW, Bonfietti LX, Matos D, Melhem MSC. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains. Diagn. Microbiol. Infect. Dis. 2012; (72): 332-9.

Silva JO, Silva P, Medeiros MIC, Carneiro AMM, Szeszs MW, Martins MA. Contribuição para a Epidemiologia da criptococose no Estado de São Paulo – dados do Instituto Adolfo Lutz de Ribeirão Preto no período de cinco anos. Bol. Inst. Adolfo Lutz. 2014; 24(1): 47-8.

Souto ACP, Bonfietti LX, Ferreira-Paim K, Trilles L, Martins M, Ribeiro-Alves M, et al. Population Genetic Analysis Reveals a High Genetic Diversity in the Brazilian Cryptococcus gattii VGII Population and Shifts the Global Origin from the Amazon Rainforest to the Semi-arid Desert in the Northeast of Brazil. Plos Negl. Trop. Dis. 2016; 10(8): e0004885.

Valério V, Melhem M, Pukinskas SRBS, Aoki S, Carrara C, Pugliese A. Actividad enzimática extracelular y serotipo en cepas de Cryptococcus neoformans de pacientes con sida en Brasil. Rev. Iberoam. Micol. 2005;(22): 29-33.

Vasconcelos DM, Domingues-Ferreira M, Soares MCP, Martins MA, Bezerra TA, Paula CR, et al. Cryptococcus gattii: immunological and microbiological study in a patient with neurocryptococcosis. JMM Case Reports. 2015. JMM Case Reports, 2015 2: 1-4